AngioDynamics ANGO Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 53.9%+3.0pp | 50.9%-0.5pp | 51.4%-1.0pp | 52.4%-1.5pp | |
| Operating margin | -13.7%+49.7pp | -63.3%-48.2pp | -15.1%-6.1pp | -9%+3.1pp | |
| Net margin | -11.6%+49.0pp | -60.7%-45.2pp | -15.5%-5.0pp | -10.5%+0.3pp | |
| Returns | |||||
| Return on equity | -17.5%+45.6pp | -63.1%-50.1pp | -13.1%-5.4pp | -7.7%-0.7pp | |
| Return on invested capital | -29.3%+44.1pp | -73.4%-60.9pp | -12.5%-5.7pp | -6.9%+1.8pp | |
| Efficiency | |||||
| Asset turnover | 1×+0.3× | 0.7×+0.1× | 0.6×+0.1× | 0.6×+0.1× | |
| Liquidity | |||||
| Current ratio | 2.2×+0.1× | 2.1×+0.2× | 2×0.0× | 1.9×-0.5× | |
| Leverage | |||||
| Debt-to-equity | 0.1×0.0× | 0×-0.1× | 0.1×+0.1× | 0.1×+0.1× | |
| Per Share | |||||
| Book value per share | $4.48-12.5% | $5.12-46.6% | $9.58-11.9% | $10.88-5.1% | |
| Valuation | |||||
| Market capitalization | $564.42M+38.7% | $252.74M-31.9% | $371.18M-51.2% | $761.25M-14.8% | |
| Price / sales | 1.8×+0.4× | 0.8×-0.3× | 1.1×-1.3× | 2.4×-0.7× | |
| Price / book | 3.3×+1.0× | 1.2×+0.2× | 1×-0.8× | 1.8×-0.2× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are AngioDynamics's profit margins?
- AngioDynamics (ANGO) runs a 54.3% gross margin and a -11.3% operating margin, with a -10.0% net margin.
- Where do AngioDynamics's ratios come from?
- Every ratio is computed from AngioDynamics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
